The Accelerating Innovations into CarE (AICE) – Market Access Program accelerates health innovations that face evidentiary hurdles in achieving market access. The Program supports small-to-medium sized enterprises (SMEs) and real-world testing sites (Testing Sites) in carrying out clinical trials, feasibility studies or real-world trials to fast-track commercial progression and market adoption.

Main Project Partners 

Project Title 

Award Date

Value

Voyageur Pharmaceuticals Ltd.

Comparative studies and regulatory approvals to facilitate market access and expansion in the radiology industry.

2025-02-01

$600,000

Syantra Inc.

Multi-biomarker RNA- and ML-based whole blood test for breast screening: validation in women at elevated risk

2025-01-15

$600,000

Pacylex Pharmaceuticals Inc.

Phase 2a clinical trial of daily oral zelenirstat in treatment refractory solid tumour patients

2024-07-01

$600,000

OraQ AI Inc.

Integration of Oral Health into Overall Health through a first of its kind, AI/ML driven medical-dental integrated OraQ Dental Wellness Score. (OWS)

2024-07-01

$600,000

Kent Imaging Inc.

SnapshotNIR Medical Imaging PAD Project

2024-02-01

$600,000

Nanostics Inc.

Commercialization of the ClarityDX Prostate test

2023-05-01

$600,000

Qualisure Diagnostics Inc.

Gaining US Market Traction for Thyroid GuidePx

2023-03-15

$600,000

Rehabtronics Inc.

Demonstration Pilots of the Prelivia Pressure Injury Prevention System

2022-01-01

$600,000

Coalese Health Systems Incorporated

Clinic Quality Improvement and Evaluation Study

2021-08-01

$244,866

Dr. Michael Hill of University of Calgary, Alberta Health Services and Forest Devices, Inc.

Surface EEG Evaluation of Prehospital Stroke (SEGUE-PS)

2021-03-01

$300,000

Circle Cardiovascular Imaging Inc.

Validation of AI-based Cardiac Image Processing Solution in Clinical Environment

2020-12-01

$300,000

Kent Imaging Inc.

Tissue oxygenation assessment in a diversified chronic wound population

2020-09-01

$252,661

Hanalytics Solutions Inc. (Zamplo)

Real World Use of the MyHealthJournal Digital Health Platform: A Critical Step Towards Building an Ecosystem of Patient-Centered Care with PROMs Data and Patient Activation

2020-06-01

$269,704

Pacylex Pharmaceuticals Inc.

Phase I Trial of PCLX-001 in Relapsed/Refractory Non-Hodgkin Lymphoma (NHL)

2020-06-01

$300,000

MEDO.ai Inc.

Hip Dysplasia Ultrasound Screening Using Artificial Intelligence: A Feasibility Study

2020-06-01

$300,000

Mikata Health Inc.

Implementation and evaluation of a conversational health technology to assess and improve the health of adults with frailty

2020-01-13

$237,795